NCT02823782

Brief Summary

Impulsivity and/or hyperactivity in children has become one of the main clinical symptom for consultation, among the most frequent, in general or pediatric medicine. Among the different clinical forms of instability, ADHD appears to be an especially disabling condition for the development of the child, both in psychomotor, cognitive, emotional and relational aspects. Further, a significant link between ADHD children and some children with High Potential (HP) is observed. HP children show overall ahead cognitive developments compared to children with the same age. In these children, as well as in children with ADHD, an attention vulnerability, psychomotor deficits are noted, as well as emotional and relational deficits that significantly contrasted with some of their cognitive skills. Regarding the HP, the hypothesis is that children with significantly heterogeneous results (Complex) to the Wechsler IV scales are affected by this shift, and hence, by the difficulty of a differential diagnosis with ADHD, unlike those whose intelligence quotient (IQ) results that are more homogeneous (Laminar). The goal of this work was to study a population of 80 children aged from 8 to 12 years (20 subjects per group) to evaluate the functional and structural brain development by:

  • Functional magnetic resonance imaging (fMRI) acquisitions with cognitive stimulations, involving attention, working memory and semantic processing, and emotional stimulations,
  • fMRI acquisitions at rest (without activation),
  • diffusion tensor magnetic resonance imaging (DTI) acquisitions,
  • 3D anatomic acquisitions. Identification of developmental differences in certain cortical brain areas (eg, prefrontal vs parietal), white matter fiber bundles or functional networks preferentially used by one or other of these groups, will help to better understand this disease, and to improve the differential diagnosis in order to implement a more appropriate and personalized management of the patients via new therapeutic strategies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 9, 2016

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 6, 2016

Completed
Last Updated

July 6, 2016

Status Verified

June 1, 2016

Enrollment Period

1.8 years

First QC Date

June 9, 2016

Last Update Submit

June 30, 2016

Conditions

Keywords

Laminar HPComplex HP

Outcome Measures

Primary Outcomes (7)

  • Cortical gray matter (GM) volumes

    using the software VBM (Voxel Based Morphometry)

    Day 1

  • Microstructural connectivity of white matter (WM) fiber bundles

    measured by diffusion tensor imaging. Diffusion metrics maps are compared using the software TBSS (Track Based Spatial Statistics),

    Day 1

  • Functional MRI activity during cognitive tests

    using the software SPM (Statistical Parametric Mapping)

    Day 1

  • Functional connectivity in resting-state fMRI

    using the CONN toolbox (functional connectivity toolbox) of SPM (Statistical Parametric Mapping)

    Day 1

  • Subcortical gray matter (GM) volumes

    using the software VBM (Voxel Based Morphometry)

    Day 1

  • Functional MRI activity during emotional tests

    using the software SPM (Statistical Parametric Mapping)

    Day 1

  • Functional connectivity in resting-state fMRI

    using the graph-theory methods

    Day 1

Study Arms (4)

Laminar HP

EXPERIMENTAL

Structural and functional MRI markers

Other: MRIOther: neuropsychological assessment

Complex HP

EXPERIMENTAL

Structural and functional MRI markers

Other: MRIOther: neuropsychological assessment

ADHD

EXPERIMENTAL

Structural and functional MRI markers

Other: MRIOther: neuropsychological assessment

Control

OTHER

Structural and functional MRI markers

Other: MRIOther: neuropsychological assessment

Interventions

MRIOTHER

MRI and neuropsychological assessment planned for the study for patient and volunteers

ADHDComplex HPControlLaminar HP
ADHDComplex HPControlLaminar HP

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Right-hand 4 groups :
  • Laminar HP : IQ \> 130 and difference between Verbal Comprehension Index (VCI) and Perceptual Reasoning Index (PRI) \< 9
  • Complex HP : IQ \> 130 and difference between VCI and PRI \>15
  • ADHD : 90 \< IQ \<110
  • Controls : 90 \< IQ \<110

You may not qualify if:

  • Subjects with any psychiatric disorders except ADHD,
  • Subjects with known learning deficits (dyslexia, dysphasia…), attention deficits except for ADHD group
  • Subjects with claustrophobia or magnetic devices
  • Children with out both parental agreements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de psychiatrie infantile, Hôpital Pierre Wertheimer, 59 Boulevard Pinel

Bron, 69500, France

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Olivier REVOL, MD

    HCL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2016

First Posted

July 6, 2016

Study Start

May 1, 2013

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

July 6, 2016

Record last verified: 2016-06

Locations